KCG
GHDX

Knight Capital Group’s Genomic Health, Inc. GHDX Stock Holding History

Knight Capital Group’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$219K Buy
+6,907
New +$227K ﹤0.01% 2607

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICM
IronBridge Capital Management Oakbrook Terrace, Illinois $1.65B AUM 18.98% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Knight Capital Group's GHDX Position: Q2 2013 in Review

Knight Capital Group opened a new position in Genomic Health, Inc. (GHDX) in Q2 2013: 6,907 shares worth $219K. The stake represents ﹤0.01% of the portfolio and ranks #2607 among its holdings.

115 funds tracked by Wall St. Rank hold GHDX as of Q2 2013.

  • Knight Capital Group held 6,907 shares of Genomic Health, Inc. worth $219K as of Q2 2013.
  • Genomic Health, Inc. was a new Knight Capital Group position in Q2 2013.
  • Genomic Health, Inc. made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #2607 holding.
  • 115 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.